MiBo Medical Group

MiBo Medical Group is a privately held manufacturer of thermal ophthalmic therapeutic devices, founded in October 2012. The company specializes in the design and manufacture of the MiBo Thermoflo, a FDA Class II exempt therapeutic medical device that utilizes UltraThermo technology to treat meibomian gland dysfunction (MGD) and lipid-deficient dry eye disease. The MiBo Thermoflo is manufactured in Plano, Texas under ISO 13485 certified processes. The device delivers controlled thermal energy to the eyelids to improve meibomian gland function and ocular surface health. MiBo Medical Group emphasizes physician-controlled costs, affordable repeat therapy, and superior patient outcomes. The company serves ophthalmologists, optometrists, and academic institutions across North America. The device has been adopted by multiple universities for clinical research and patient care. Marketing focuses on ease of use, immediate patient results, elimination of subscription fees, and practitioner satisfaction. The company is located in the Dallas-Fort Worth area of Texas.